Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
The company is moving towards complex and more differentiated products
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Nelarabine is in a class of medications called antimetabolites
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The drug helps in managing cholesterol
Subscribe To Our Newsletter & Stay Updated
